Risk of critical congenital heart defects by nuchal translucency norms

American Journal of Obstetrics and Gynecology

Volumn 212, Issue 4, 2015, Pages 518.e1-518.e10

  Jelliffe Pawlowski, Laura L ^a,b   Norton, Mary E ^b   Shaw, Gary M ^c   Baer, Rebecca J ^a   Flessel, Monica C ^a   Goldman, Sara ^a   Currier, Robert J ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

critical congenital heart defect; nuchal translucency; prenatal screening

Indexed keywords

AORTA COARCTATION; AORTA VALVE STENOSIS; ARTICLE; CONGENITAL HEART MALFORMATION; CROWN RUMP LENGTH; EBSTEIN ANOMALY; ENDOCARDIAL CUSHION DEFECT; FALLOT TETRALOGY; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GREAT VESSELS TRANSPOSITION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; LIVE BIRTH; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PULMONARY VALVE DISEASE; RISK ASSESSMENT; TRICUSPID VALVE ATRESIA; TRICUSPID VALVE STENOSIS; ADULT; ECHOGRAPHY; EVALUATION STUDY; FEMALE; PREGNANCY; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; CROWN-RUMP LENGTH; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; LOGISTIC MODELS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK; SENSITIVITY AND SPECIFICITY;

EID: 84930408657     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.10.1102     Document Type: Article

References (41)

1. L.D. Botto, A. Correa, and J.D. Erickson Racial and temporal variations in the prevalence of heart defects Pediatrics 107 2001 E32
2. M.D. Reller, M.J. Strickland, T. Riehle-Colarusso, W.T. Mahle, and A. Correa Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005 J Pediatr 153 2008 807 813
3. K. Bjornard, T. Riehle-Colarusso, S.M. Gilboa, and A. Correa Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005 Birth Defects Res A Clin Mol Teratol 97 2013 87 94
4. D. Bonnet, A. Coltri, and G. Butera Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality Circulation 99 1999 916 918
5. W.T. Mahle, R.R. Clancy, S.P. McGaurn, J.E. Goin, and B.J. Clark Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome Pediatrics 107 2001 1277 1282
6. P.M. Verheijen, L.A. Lisowski, and P. Stoutenbeek Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient J Thorac Cardiovasc Surg 121 2001 798 803
7. B. Khoshnood, C. De Vigan, and V. Vodovar Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation Pediatrics 115 2005 95 101
8. A. Levey, J.S. Glickstein, and C.S. Kleinman The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes Pediatr Cardiol 31 2010 587 597
9. J. Hyett, G. Moscoso, G. Papapanagiotou, M. Perdu, and K.H. Nicolaides Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation Ultrasound Obstet Gynecol 7 1996 245 250
10. C.M. Bilardo, E. Pajkrt, I. de Graaf, B.W. Mol, and O.P. Bleker Outcome of fetuses with enlarged nuchal translucency and normal karyotype Ultrasound Obstet Gynecol 11 1998 401 406
11. L.L. Simpson, F.D. Malone, and D.W. Bianchi Nuchal translucency and the risk of congenital heart disease Obstet Gynecol 109 2007 376 383
12. S.A. Clur, J. Ottenkamp, and C.M. Bilardo The nuchal translucency and the fetal heart: a literature review Prenat Diagn 29 2009 739 748
13. R.O. Bahado-Singh, R. Wapner, and E. Thom Elevated first-trimester nuchal translucency increases the risk of congenital heart defects Am J Obstet Gynecol 192 2005 1357 1361
14. American College of Obstetricians and Gynecologists Screening for fetal chromosomal abnormalities. ACOG Practice bulletin no. 77 Obstet Gynecol 109 2007 217 227
15. UK National Health Service (NHS) FASP. Nuchal translucency greater than or equal to 3.5mm. Programme Statement. Exeter, United Kingdom: UK National Screening Committee; 2006. Available at: http://fetalanomaly.screening.nhs.uk/programmestatements. Accessed Oct. 28, 2014.
16. N. Wu, L.D. Platt, N. Greene, and R.J. Currier Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance Obstet Gynecol 119 2012 785 794
17. Nuchal Translucency Quality Review Program website, 2014. Available at: www.ntqr.org. Accessed June 20, 2014.
18. Fetal Medicine Foundation website, 2014. Availabale at: www.fetalmedicineusa.com. Accessed June 20, 2014.
19. M.I. Evans, D.H. Van, and K.H. Nicolaides Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy Fetal Diagn Ther 22 2007 401 404
20. L.L. Jelliffe-Pawlowski, L. Walton-Haynes, and R.J. Currier Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results Am J Med Genet A 146A 2008 2455 2467
21. N.N. Kazerouni, B. Currier, and L. Malm Triple-marker prenatal screening program for chromosomal defects Obstet Gynecol 114 2009 50 58
22. L. Jelliffe-Pawlowski, R. Baer, A.J. Moon-Grady, and R.J. Currier Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects Prenat Diagn 31 2011 466 472
23. N.N. Kazerouni, R.J. Currier, and M. Flessel Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009 Prenat Diagn 31 2011 901 906
24. L.L. Jelliffe-Pawlowski, G.M. Shaw, and R.J. Currier Association of early-preterm birth with abnormal levels of routinely collected first-and second-trimester biomarkers Am J Obstet Gynecol 208 2013 492.e1 492.e11
25. American Medical Association International Classification of Diseases; Physician, Ninth Revision Clinical Modification 9 ed. 2008 American Medical Association Chicago
26. J.A. Hyett Increased nuchal translucency in fetuses with a normal karyotype Prenat Diagn 22 2002 864 868
27. C.M. Bilardo, E. Timmerman, E. Pajkrt, and M. van Marrle Increased nuchal translucency in euploid fetuses: what should we be telling the parents? Prenat Diagn 30 2010 93 102
28. J. Hyett, M. Perdu, G. Sharland, R. Snijders, and K.H. Nicolaides Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study BMJ 318 1999 81 85
29. M. Westin, S. Saltvedt, G. Bergman, H. Almstrom, C. Grunewald, and L. Valentin Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses Ultrasound Obstet Gynecol 27 2006 632 639
30. P. Pradat, C. Francannet, J.A. Harris, and E. Robert The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations Pediatr Cardiol 24 2003 195 221
31. A. Miller, T. Riehle-Colarusso, C.J. Alverson, J.L. Frias, and A. Correa Congenital heart defects and major structural noncardiac anomalies, Atlanta, Georgia, 1968 to 2005 J Pediatr 159 2011 70 78
32. D.A. Krantz, T.W. Hallahan, V.J. Macri, and J.N. Macri Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program Prenat Diagn 25 2005 635 640
33. K. Spencer, V. Heath, A. El-Sheikhah, C.Y. Ong, and K.H. Nicolaides Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations Prenat Diagn 25 2005 365 369
34. D.S. Sahota, T.Y. Leung, T.Y. Fung, L.W. Chan, L.W. Law, and T.K. Lau Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21 Ultrasound Obstet Gynecol 33 2009 387 393
35. Stillbirth Collaborative Research Network Writing Group Causes of death among stillbirths JAMA 306 2011 2459 2468
36. K. Tararbit, T.T. Bui, N. Lelong, A.C. Thieulin, F. Goffinet, and B. Khoshnood Clinical and socioeconomic predictors of pregnancy termination for fetuses with congenital heart defects: a population-based evaluation Prenat Diagn 33 2013 179 186
37. W.T. Mahle, J.W. Newburger, and G.P. Matherne Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP Pediatrics 124 2009 823 836
38. A.M. Atz, T.G. Travison, and I.A. Williams Prenatal diagnosis and risk factors for preoperative death in neonates with single right ventricle and systemic outflow obstruction: screening data from the Pediatric Heart Network Single Ventricle Reconstruction Trial(∗) J Thorac Cardiovasc Surg 140 2010 1245 1250
39. B.J. Landis, A. Levey, and S.M. Levasseur Prenatal diagnosis of congenital heart disease and birth outcomes Pediatr Cardiol 34 2013 597 605
40. S.A. Clur, P.M. Van Brussel, J. Ottenkamp, and C.M. Bilardo Prenatal diagnosis of cardiac defects: accuracy and benefit Prenat Diagn 32 2012 450 455
41. F.P. Hadlock, Y.P. Shah, D.J. Kanon, and J.V. Lindsey Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US Radiology 182 1992 501 505.